• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC. PROCOL BIOLOGIC VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC. PROCOL BIOLOGIC VASCULAR GRAFT Back to Search Results
Catalog Number HJL016-40-N
Device Problem Material Integrity Problem (2978)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/15/2019
Event Type  malfunction  
Manufacturer Narrative
We have not received the graft for evaluation since the graft has been implanted.Hence, we could not conclusively determine the cause of the failure.Procol vacular bioprosthesis is derived from a single length of bovine mesenteric vein that is chemically cross-linked with glutaraldehyde.Natural variations even in the same graft is possible.Collateral branches are ligated with surgical suture and the graft is inspected under pulsatile flow conditions at simulated physiological internal graft pressure.Each graft is pressurized between 2.7-4.0 psi ( 139 - 206 mmhg) during inspection process.If pressure exceeds 4 psi, the vessel is rejected for 'overpressurized' and discarded.Under pressurized condition, each graft is inspected by the manufacturing operators for any presence of hole, tear or swelling.An od gage is passed over the entire length of the vessel.If any section of the graft appeared to be swollen or did not pass through the gage smoothly, then that section of the graft is rejected by the technician.Each graft is again inspected by the qc technician for these attributes.We have conducted a lot history review and did not find any issues noted in the manufacturing or packaging process that could be related to this issue.All qc tests passed their requirements.Further, we have not received any other complaints of a similar nature related to other grafts that were manufactured in this batch.Based on our investigation and our sales rep's observation, the graft was likely damaged due to over-pressurization when irrigating the lumen of the graft prior to the procedure at the hospital.He observed the prep nurse to be pressurizing the graft with a 20cc syringe prior to hand off.With this information, we were able to recreate a similar malfunction with a new graft using a pressure gauge.We observed pressure as high as 15 psi which is 5 times higher than normal human blood pressure.Our sales rep.Is scheduled to retrain the surgical team on proper irrigation procedure.Our ifu properly instructs users to use light pressure when irrigating the graft and not to flush the graft opposite the direction of flow as competent valves may cause excessive pressure and may compromise the integrity of the vessel.The ifu also informs users not to use forceps to grip the graft as it may damage the graft.
 
Event Description
Surgeon used a procol vascular bioprosthesis for creating a bridge graft for vascular access to a dialysis patient.After surgeon completed the arterial anastomosis, upon pressurizing the graft, he observed an aneurysmal spot on the graft.Surgeon trimmed a distal end of the graft and used it to patch this spot.There was no injury to the patient as the result of this incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROCOL BIOLOGIC VASCULAR GRAFT
Type of Device
VASCULAR GRAFT
Manufacturer (Section D)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer (Section G)
LEMAITRE VASCULAR
63 second ave
burlington MA 01803
Manufacturer Contact
pragya thikey
63 second ave
burlington, MA 01803
7812212266
MDR Report Key9047333
MDR Text Key178784312
Report Number1220948-2019-00127
Device Sequence Number1
Product Code LXA
UDI-Device Identifier00840663108688
UDI-Public00840663108688
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 09/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/13/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/28/2023
Device Catalogue NumberHJL016-40-N
Device Lot NumberPVB1032
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/16/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/18/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-